NewsBenzingaLifecore Biomedical: el BPA del tercer trimestre de $(1.08) no alcanza la estimación de $(0.28); las ventas de $25.322 millones no alcanzan la estimación de $26.699 millones. Lifecore Biomedical: el BPA del tercer trimestre de $(1.08) no alcanza la estimación de $(0.28); las ventas de $25.322 millones no alcanzan la estimación de $26.699 millones. Benzinga 2026.11.04 12:24 (GMT+0) Open on Benzinga Other news Is Wall Street Bullish or Bearish on CSX Corporation Stock? Are Wall Street Analysts Bullish on Microchip Technology Stock? Andy Jassy’s AWS Grows at the Fastest Rate in 5 Years, Yet Amazon Stock Falls After Earnings. Blame the Spending. For Those Seeking AI Stocks Poised to Soar, This Little-Known Chip-Equipment Maker Is a Good Fit What Are Wall Street Analysts' Target Price for Johnson Controls Stock? Exelon Stock Outlook: Is Wall Street Bullish or Bearish?
Andy Jassy’s AWS Grows at the Fastest Rate in 5 Years, Yet Amazon Stock Falls After Earnings. Blame the Spending.
